NF-κB Inhibition in Amyotrophic Lateral Sclerosis
NCT05031351
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
75
Enrollment
OTHER
Sponsor class
Conditions
ALS
Interventions
DRUG:
Withania somnifera
DRUG:
Placebo
Sponsor
Sunnybrook Health Sciences Centre